Johanna A. Jorgensen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Johanna A. Jorgensen has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Gert Schaart
Department of Nutrition and Movement Sciences, NUTRIM Institute of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands
2 shared publications - Joris Hoeks
Department of Nutrition and Movement Sciences, NUTRIM Institute of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands
2 shared publications - Patrick Schrauwen
Institute for Clinical Diabetology, German Diabetes Center, Leibniz Institute for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany
2 shared publications - Adam Jake Sellers
Department of Nutrition and Movement Sciences, NUTRIM Institute of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands
1 shared publication - Aditi R. Saxena
Pfizer Worldwide Research and Development Cambridge Massachusetts USA
1 shared publication - Anna Veelen
Department of Nutrition and Movement Sciences, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center, Maastricht, The Netherlands
1 shared publication
Latest Publications
- 7 October 2026
- Published by Springer Nature in Nature Metabolism
- Vol. 8 (10) , 2165-2177
Metabolic benefits of ketohexokinase inhibition in individuals with MASLD: a randomized placebo-controlled crossover trial
- 7 October 2026
- Published by Springer Nature in Nature Metabolism
- Vol. 8 (10) , 2165-2177
Metabolic benefits of ketohexokinase inhibition in individuals with MASLD: a randomized placebo-controlled crossover trial
- Open Access
- 12 May 2026
- Published by Springer Nature in Diabetologia
- Vol. 69 (8) , 2347-2359
Nocturnal fat oxidation is lower in older individuals with overweight/obesity, including those with type 2 diabetes, and is associated with fasting triglyceride levels
Aims/hypothesis: We previously showed that nocturnal fat oxidation is reduced in older individuals with overweight/obesity and impaired glucose tolerance and insulin sensitivity compared with young lean individuals. Here, we compared nocturnal energy expenditure and substrate oxidation across groups varying in age, body composition and metabolic status to unravel factors underlying variations in nocturnal substrate metabolism. Methods: Data were collected from 18 previously conducted human clinical studies ( N =187), all performed under conditions of energy balance with similar diet composition and meal timing. Individuals were categorised into four groups: young lean (YL); older lean (OL); older with overweight/obesity (OBE); and older with overweight/obesity and type 2 diabetes (T2D). Nocturnal energy expenditure and substrate oxidation were determined by whole-room indirect calorimetry, body composition was assessed by air-displacement plethysmography or dual energy x-ray absorptiometry, and glucose, insulin, HOMA-IR, NEFA and triglycerides were measured from fasted blood samples. Group comparisons for nocturnal energy expenditure and substrate oxidation were performed using Kruskal–Wallis tests, and over time using linear mixed models including group × time interactions, with Bonferroni correction applied to both analyses. Multivariate linear regression analysis was applied to identify whether age, sex, HOMA-IR, fasting NEFA, fasting triglycerides, fat mass and fat-free mass were independent factors of nocturnal energy expenditure and substrate oxidation. Results: Nocturnal energy expenditure, adjusted for fat-free mass, was higher in OBE compared with YL and OL ( p p p p <0.01 for both). Standardised linear regression models revealed that fasting triglycerides were positively associated with nocturnal respiratory exchange ratio (β=0.337; 95% CI 0.165, 0.508) and nocturnal carbohydrate oxidation (% of energy expenditure; β=0.337; 95% CI 0.166, 0.509), and inversely associated with nocturnal fat oxidation (% of energy expenditure; β=−0.352; 95% CI −0.520, −0.813). Conclusions/interpretation: Nocturnal fat oxidation (% of energy expenditure) is diminished in older individuals with overweight/obesity, irrespective of diabetes status. No differences in nocturnal energy expenditure (adjusted for fat-free mass) or substrate oxidation were observed between young and older lean individuals, suggesting that age per se may not strongly influence nocturnal substrate metabolism. Fasting triglyceride level was the strongest associated factor of nocturnal substrate oxidation.
- 12 May 2026
- Published by Springer Nature in Diabetologia
- Vol. 69 (8) , 2347-2359
Open AccessNocturnal fat oxidation is lower in older individuals with overweight/obesity, including those with type 2 diabetes, and is associated with fasting triglyceride levels
Aims/hypothesis: We previously showed that nocturnal fat oxidation is reduced in older individuals with overweight/obesity and impaired glucose tolerance and insulin sensitivity compared with young lean individuals. Here, we compared nocturnal energy expenditure and substrate oxidation across groups varying in age, body composition and metabolic status to unravel factors underlying variations in nocturnal substrate metabolism. Methods: Data were collected from 18 previously conducted human clinical studies ( N =187), all performed under conditions of energy balance with similar diet composition and meal timing. Individuals were categorised into four groups: young lean (YL); older lean (OL); older with overweight/obesity (OBE); and older with overweight/obesity and type 2 diabetes (T2D). Nocturnal energy expenditure and substrate oxidation were determined by whole-room indirect calorimetry, body composition was assessed by air-displacement plethysmography or dual energy x-ray absorptiometry, and glucose, insulin, HOMA-IR, NEFA and triglycerides were measured from fasted blood samples. Group comparisons for nocturnal energy expenditure and substrate oxidation were performed using Kruskal–Wallis tests, and over time using linear mixed models including group × time interactions, with Bonferroni correction applied to both analyses. Multivariate linear regression analysis was applied to identify whether age, sex, HOMA-IR, fasting NEFA, fasting triglycerides, fat mass and fat-free mass were independent factors of nocturnal energy expenditure and substrate oxidation. Results: Nocturnal energy expenditure, adjusted for fat-free mass, was higher in OBE compared with YL and OL ( p p p p <0.01 for both). Standardised linear regression models revealed that fasting triglycerides were positively associated with nocturnal respiratory exchange ratio (β=0.337; 95% CI 0.165, 0.508) and nocturnal carbohydrate oxidation (% of energy expenditure; β=0.337; 95% CI 0.166, 0.509), and inversely associated with nocturnal fat oxidation (% of energy expenditure; β=−0.352; 95% CI −0.520, −0.813). Conclusions/interpretation: Nocturnal fat oxidation (% of energy expenditure) is diminished in older individuals with overweight/obesity, irrespective of diabetes status. No differences in nocturnal energy expenditure (adjusted for fat-free mass) or substrate oxidation were observed between young and older lean individuals, suggesting that age per se may not strongly influence nocturnal substrate metabolism. Fasting triglyceride level was the strongest associated factor of nocturnal substrate oxidation.
- 6 December 2024
- Published by Springer Nature in Nature Metabolism
- Vol. 6 (12) , 2246-2253
Cold acclimation with shivering improves metabolic health in adults with overweight or obesity
Cold acclimation increases insulin sensitivity, and some level of muscle contraction appears to be needed for provoking this effect. Here 15 men and (postmenopausal) women with overweight or obesity, the majority of whom had impaired glucose tolerance, were intermittently exposed to cold to induce 1 h of shivering per day over 10 days. We determined the effect of cold acclimation with shivering on overnight fasted oral glucose tolerance (primary outcome) and on skeletal muscle glucose transporter 4 translocation (secondary outcome). We find that cold acclimation with shivering improves oral glucose tolerance, fasting glucose, triglycerides, non-esterified fatty acid concentrations and blood pressure. Cold acclimation with shivering may thus represent an alternative lifestyle approach for the prevention and treatment of obesity-related metabolic disorders. ClinicalTrials.gov registration: NCT04516018.
- 6 December 2024
- Published by Springer Nature in Nature Metabolism
- Vol. 6 (12) , 2246-2253
Cold acclimation with shivering improves metabolic health in adults with overweight or obesity
Cold acclimation increases insulin sensitivity, and some level of muscle contraction appears to be needed for provoking this effect. Here 15 men and (postmenopausal) women with overweight or obesity, the majority of whom had impaired glucose tolerance, were intermittently exposed to cold to induce 1 h of shivering per day over 10 days. We determined the effect of cold acclimation with shivering on overnight fasted oral glucose tolerance (primary outcome) and on skeletal muscle glucose transporter 4 translocation (secondary outcome). We find that cold acclimation with shivering improves oral glucose tolerance, fasting glucose, triglycerides, non-esterified fatty acid concentrations and blood pressure. Cold acclimation with shivering may thus represent an alternative lifestyle approach for the prevention and treatment of obesity-related metabolic disorders. ClinicalTrials.gov registration: NCT04516018.